Vik Chopra

Stock Analyst at BMO Capital

(1.80)
# 3,353
Out of 5,022 analysts
228
Total ratings
41.2%
Success rate
0.1%
Average return

Stocks Rated by Vik Chopra

Envista Holdings
Sep 28, 2026
Reiterated: Hold
Price Target: $29 → $26
Current: $23.16
Upside: +12.26%
DENTSPLY SIRONA
Sep 16, 2026
Rated: Hold
Price Target: $13 → $10
Current: $8.74
Upside: +14.42%
GE HealthCare Technologies
Sep 13, 2026
Reiterated: Hold
Price Target: $71
Current: $63.98
Upside: +10.97%
Stryker
Sep 9, 2026
Reiterated: Buy
Price Target: $369 → $317
Current: $272.96
Upside: +16.13%
Enovis
Sep 1, 2026
Rated: Buy
Price Target: $30 → $27
Current: $18.05
Upside: +49.58%
Intuitive Surgical
Aug 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $401.24
Upside: -
Globus Medical
Aug 27, 2026
Reiterated: Buy
Price Target: $94
Current: $74.41
Upside: +26.33%
Solventum
Aug 17, 2026
Reiterated: Hold
Price Target: $84
Current: $87.77
Upside: -4.30%
Align Technology
Aug 12, 2026
Reiterated: Buy
Price Target: $209
Current: $145.35
Upside: +43.80%
Zimmer Biomet Holdings
Aug 6, 2026
Reiterated: Hold
Price Target: $95 → $96
Current: $88.06
Upside: +9.02%
Rated: Buy
Price Target: $11 → $12
Current: $9.90
Upside: +21.21%
Reiterated: Hold
Price Target: $85
Current: $84.93
Upside: +0.08%
Reiterated: Hold
Price Target: $19 → $18
Current: $16.09
Upside: +11.87%
Reiterated: Hold
Price Target: $36 → $45
Current: $45.93
Upside: -2.02%
Reiterated: Buy
Price Target: n/a
Current: $91.54
Upside: -
Initiated Coverage: Buy
Price Target: $159
Current: $126.11
Upside: +26.08%
Reiterated: Buy
Price Target: $15 → $19
Current: $13.15
Upside: +44.49%
Reiterated: Buy
Price Target: $109
Current: $85.19
Upside: n/a